Latest
on the worldwide spread of coronavirus
Send a link to a friend
[October 23, 2020]
(Reuters) - Europe's reported coronavirus
cases more than doubled in 10 days, crossing 200,000 daily infections
for the first time on Thursday, according to a Reuters tally, with many
Southern European countries reporting their highest single-day cases
this week.
|
DEATHS AND INFECTIONS
* For an interactive graphic tracking the global spread of COVID-19,
open
https://graphics.reuters.com/
world-coronavirus-tracker-and-maps in an external browser.
* Eikon users, see COVID-19: MacroVitals
https://apac1.apps.
cp.thomsonreuters.com/cms/?navid=1592404098 for a case tracker and
summary of news.
EUROPE
* Germany is making preparations to start vaccinations against the
coronavirus before the end of the year, Bild daily reported on
Friday.
AMERICAS
* The Peruvian government refused to sign a coronavirus vaccine
purchase agreement with AstraZeneca PLC because it did not provide
sufficient data from its studies and offered minimal amounts of
inoculations.
* The United States, state governments and some foreign countries
should replace quarantines and travel bans on airline passengers
with COVID-19 testing of travelers before departure and upon
arrival, airline and business groups said.
* Several U.S. states, many of them in the Midwest, reported record
single-day increases in cases.
ASIA-PACIFIC
* The Japanese government's expert panel to combat the pandemic
plans to propose on Friday extending the New Year holidays by about
a week to Jan. 11, Kyodo News reported.
* Australia's Victoria state - the epicentre of the country's
COVID-19 outbreak - reported that active coronavirus cases have
fallen to a four-month low, paving the way for an acceleration in
the easing of social distancing curbs.
* The Philippines' coronavirus task force has approved the entry of
foreign investors to the Southeast Asian nation starting from Nov.
1.
[to top of second column] |
MIDDLE EAST AND AFRICA
* Ethiopia can jail people for up to two years if they deliberately violate
COVID-19 restrictions, the attorney general's office said, amid concern that
citizens are becoming lax after a state of emergency was lifted.
MEDICAL DEVELOPMENTS
* The U.S. FDA approved Gilead Sciences Inc's antiviral drug remdesivir for
treating patients hospitalized with COVID-19, making it the first and only drug
approved for the disease.
* Using blood of recovered COVID-19 patients - or so-called convalescent plasma
- as a potential treatment is of little benefit in helping hospitalised patients
fight off the infection, according to results of a clinical trial in India.
ECONOMIC IMPACT
* Global stocks barely budged on Friday as investors tightened positions with
less than two weeks to go before the U.S. presidential election and awaited a
breakthrough in stimulus talks in Washington. [MKTS/GLOB]
* White House Chief of Staff Mark Meadows said negotiations with lawmakers on a
coronavirus relief package, now totaling $1.9 trillion, have entered a new phase
with congressional committee chairs meeting.
* Japan's core consumer prices slipped for the second consecutive month in
September, a sign that a coronavirus-induced demand downturn is piling
deflationary pressure on the world's third-largest economy already blighted by
recession.
* The euro zone's economic recovery is at serious risk of stalling as a
resurgent coronavirus sweeps through Europe, according to economists in a
Reuters poll.
(Compiled by Devika Syamnath and Amy Caren Daniel; Editing by Anil D'Silva and
Sriraj Kalluvila)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |